PM&R Journal Club
Topics: Risk of Dementia following Gabapentin prescription in chronic low back pain patients
Speakers: Austin J. Eells, MD
Topics: Feasibility and acceptability of the Comprehensive Oncology Rehabilitation and Exercise (CORE) clinical workflow algorithm in patients with newly diagnosed stage I-III breast cancer who undergo surgery as first-line treatment
Speakers: Nandita S. Keole, MD
Date: Wednesday, August 13, 2025
Time: 7:00 – 8:00 am
TEAMS link sent to staff
Learning Objectives
Upon completion of this activity, participants should be able to:
- Evaluate the relationship between the frequency of Gabapentin prescriptions and the risk of dementia in adults with chronic low back pain.
- Differentiate the risks of dementia between elderly and non-elderly prescribed Gabapentin for chronic low back pain.
- Critique the study's methodology including strengths and benefits of the study design.
- Describe the role of prehabilitation in optimizing functional outcomes in oncology patients.
- Propose a structured model for delivering prehabilitation to cancer patients.
- Develop a physiarty-led systematic framework for triaging patients to appropriate prehabilitation services.
- Evaluate strategies for implementing and optimizing prehabilitation services within oncology workflows.
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Facebook
X
LinkedIn
Forward